These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16340628)

  • 21. To Bravo or not? A comparison of wireless esophageal pH monitoring and conventional pH catheter to evaluate non-erosive gastroesophageal reflux disease in a multiracial Asian cohort.
    Ang D; Teo EK; Ang TL; Ong J; Poh CH; Tan J; Fock KM
    J Dig Dis; 2010 Feb; 11(1):19-27. PubMed ID: 20132427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 48-Hour pH monitoring increases the risk of false positive studies when the capsule is prematurely passed.
    Iqbal A; Lee YK; Vitamvas M; Oleynikov D
    J Gastrointest Surg; 2007 May; 11(5):638-41. PubMed ID: 17468923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical utility and tolerability of JSPH-1 wireless esophageal pH monitoring system.
    Li JN; Liu CL; Tao XH
    BMC Gastroenterol; 2013 Jan; 13():10. PubMed ID: 23317032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review article: oesophageal pH monitoring--technologies, interpretation and correlation with clinical outcomes.
    Kahrilas PJ; Pandolfino JE
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():2-9. PubMed ID: 16303031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wireless esophageal pH monitoring: new technique means new questions.
    Bhat YM; McGrath KM; Bielefeldt K
    J Clin Gastroenterol; 2006 Feb; 40(2):116-21. PubMed ID: 16394871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Bravo pH capsule system.
    Kwiatek MA; Pandolfino JE
    Dig Liver Dis; 2008 Mar; 40(3):156-60. PubMed ID: 18096447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use and utility of the Bravo pH capsule.
    Pandolfino JE; Kwiatek MA
    J Clin Gastroenterol; 2008; 42(5):571-8. PubMed ID: 18364590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ambulatory pH: monitoring with a wireless system.
    Schneider JH; Kramer KM; Königsrainer A; Granderath FA
    Surg Endosc; 2007 Nov; 21(11):2076-80. PubMed ID: 17484003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonendoscopic transnasal placement of a wireless capsule for esophageal pH monitoring: feasibility, safety, and efficacy of a manometry-guided procedure.
    Marchese M; Spada C; Iacopini F; Familiari P; Shah SG; Tringali A; Costamagna G
    Endoscopy; 2006 Aug; 38(8):813-8. PubMed ID: 17001571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ambulatory esophageal pH monitoring by using a wireless system: a pilot study in Taiwan.
    Tu CH; Lee YC; Wang HP; Wu MS; Chiu HM; Lin JT
    Hepatogastroenterology; 2004; 51(60):1586-9. PubMed ID: 15532783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo).
    des Varannes SB; Mion F; Ducrotté P; Zerbib F; Denis P; Ponchon T; Thibault R; Galmiche JP
    Gut; 2005 Dec; 54(12):1682-6. PubMed ID: 15843417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of esophageal acid exposure at 1 cm and 6 cm above the squamocolumnar junction using the Bravo pH monitoring system.
    Pandolfino JE; Lee TJ; Schreiner MA; Zhang Q; Roth MP; Kahrilas PJ
    Dis Esophagus; 2006; 19(3):177-82. PubMed ID: 16722995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Day-to-day discrepancy in Bravo pH monitoring is related to the degree of deterioration of the lower esophageal sphincter and severity of reflux disease.
    Ayazi S; Hagen JA; Zehetner J; Banki F; Augustin F; Ayazi A; DeMeester SR; Oh DS; Sohn HJ; Lipham JC; DeMeester TR
    Surg Endosc; 2011 Jul; 25(7):2219-23. PubMed ID: 21359906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acid reflux event detection using the Bravo wireless versus the Slimline catheter pH systems: why are the numbers so different?
    Pandolfino JE; Zhang Q; Schreiner MA; Ghosh S; Roth MP; Kahrilas PJ
    Gut; 2005 Dec; 54(12):1687-92. PubMed ID: 15923666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bravo capsule placement in the gastric cardia: a novel method for analysis of proximal stomach acid environment.
    Pandolfino JE; Schreiner MA; Lee TJ; Zhang Q; Kahrilas PJ
    Am J Gastroenterol; 2005 Aug; 100(8):1721-7. PubMed ID: 16086707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Four-day Bravo pH capsule monitoring with and without proton pump inhibitor therapy.
    Hirano I; Zhang Q; Pandolfino JE; Kahrilas PJ
    Clin Gastroenterol Hepatol; 2005 Nov; 3(11):1083-8. PubMed ID: 16271338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 48-hour wireless oesophageal pH-monitoring in children: are two days better than one?
    Gunnarsdóttir A; Stenström P; Arnbjörnsson E
    Eur J Pediatr Surg; 2007 Dec; 17(6):378-81. PubMed ID: 18072019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 24-h multichannel intraluminal impedance-pH monitoring may be an inadequate test for detecting gastroesophageal reflux in patients with mixed typical and atypical symptoms.
    Han MS; Lada MJ; Nieman DR; Tschoner A; Peyre CG; Jones CE; Watson TJ; Peters JH
    Surg Endosc; 2015 Jul; 29(7):1700-8. PubMed ID: 25398192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of wireless 48-h (Bravo) versus traditional ambulatory 24-h esophageal pH monitoring.
    Håkanson BS; Berggren P; Granqvist S; Ljungqvist O; Thorell A
    Scand J Gastroenterol; 2009; 44(3):276-83. PubMed ID: 19040176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bravo capsule for wireless 48-h pH monitoring: proposed algorithm for its placement.
    Marchese M; Spada C; Costamagna G
    Am J Gastroenterol; 2007 Sep; 102(9):2104-5; author reply 2106. PubMed ID: 17727439
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.